简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-11-01 14:56 Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics
2024-11-01 14:43 ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm
2024-11-01 14:39 Myrobalan Therapeutics Appoints Robin Kleiman Ph.D., as Chief Scientific Officer
2024-10-31 14:46 Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
2024-10-31 09:45 Opening of Biosynth Biological Technology; a new Cutting-Edge Facility at Lifebay in Suzhou, China
2024-10-30 17:27 ADx NeuroSciences and Alamar Biosciences Announce Partnership to Provide Customized Blood-Based Biomarker Assay Solutions to Accelerate Biopharma Clinical Development
2024-10-30 15:03 Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually
2024-10-30 14:16 Organon Completes Acquisition of Dermavant, including Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
2024-10-30 10:20 World Stroke Organization Launches Global Coalition to Drive Policy Action on Stroke Care
2024-10-29 15:16 BeiGene Mourns Death of Beloved Board Member Donald Glazer
2024-10-29 10:22 Boomi Partners with BASE life science to Accelerate Digital Transformation Across the Life Sciences Industry
2024-10-25 15:46 Galderma Brings Together Over 650 Healthcare Professionals from Asia-Pacific to Elevate Knowledge of Future Aesthetic Trends
2024-10-24 13:07 Galderma Delivers Record Net Sales of 3.259 B USD in the First Nine Months of 2024, Demonstrates Significant Innovation Progress, Confirms and Narrows Its Full Year Net Sales Guidance
2024-10-23 10:14 BeiGene Receives Positive CHMP Opinions for TEVIMBRA® as a First-Line Treatment for Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer and Esophageal Squamous Cell Carcinoma
2024-10-22 17:42 HemoHim Manufacturer Kolmar BNH Receives NAI Classification from the US FDA
2024-10-21 13:22 ASDS 2024: New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma’s RelabotulinumtoxinA (Relfydess™)
2024-10-18 10:27 Celltrion presents 2-year post-hoc analysis findings for subcutaneous infliximab (CT-P13 SC), highlighting dose escalation as an option for managing loss of response in inflammatory bowel disease
2024-10-18 09:42 Medidata Announces Rave Lite to Support Growth in Early and Late-Stage Clinical Trials
2024-10-17 10:11 Myrobalan Therapeutics Strengthens Board of Directors with Appointment of Emma Reeve
2024-10-16 16:06 Aster Guardians Global Nursing Award Announces Top 10 Finalists for 2024

Business Wire Weibo

Press Releases

Latest Releases